🔎 Trials Near Me

Akèy › Twoub san › New York › New York City

Etid klinik pou Twoub san nan New York City, NY

7 etid pou Twoub san ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Memorial Sloan Kettering Cancer Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Memorial Sloan Kettering Cancer Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

Ap rekriteEtid obsèvasyon
  • Weill Cornell Medical College - New York Presbyterian Hospital, New York
Tout laj · Tout sèks · Mizajou Aug 17, 2026 · NCT04398628

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Ap rekriteFaz 2
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07216443

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Ap rekriteFaz 2/3
  • Perlmutter Cancer Center - 34th Street, New York
  • Icahn School of Medicine at Mount Sinai, New York
Laj 18 ak plis · Tout sèks · Mizajou Apr 30, 2026 · NCT04256317

Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease

Ap rekriteFaz 3
  • New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
Laj 12 a 35 · Tout sèks · Mizajou Mar 23, 2026 · NCT05477563

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Ap rekriteFaz 1
  • Columbia University, New York
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2025 · NCT05423691

Etid Twoub san nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.